300896 logo

Imeik Technology Development Co.,Ltd. Stock Price

SZSE:300896 Community·CN¥29.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

300896 Share Price Performance

CN¥0
-175.25 (-100.00%)
CN¥0
-175.25 (-100.00%)
Price CN¥0

300896 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and undervalued.

1 Risk
3 Rewards

Imeik Technology Development Co.,Ltd. Key Details

CN¥2.4b

Revenue

CN¥186.8m

Cost of Revenue

CN¥2.2b

Gross Profit

CN¥1.1b

Other Expenses

CN¥1.1b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
3.80
92.29%
47.28%
0%
View Full Analysis

About 300896

Founded
2004
Employees
1458
CEO
Yifeng Shi
WebsiteView website
www.imeik.net/cn/

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions. The company was incorporated in 2004 and is headquartered in Beijing, China.

Recent 300896 News & Updates

Recent updates

No updates